PERK levels are significantly elevated in various cancers, including kidney renal papillary cell carcinoma, lower-grade glioma of the brain, invasive breast carcinoma, thyroid carcinoma, and neck squamous cell carcinoma. Here, EIF2AK3 is linked to cancer.